• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯甲酰肼衍生物对红细胞碳酸酐酶同工酶的抑制谱和分子对接分析。

Inhibition Profiles and Molecular Docking Analysis of Benzohydrazide Derivatives on Red Blood Cell Carbonic Anhydrases Isozymes.

机构信息

Department of Chemistry, Faculty of Science, Atatürk University, Erzurum, 25240, Turkey.

Department of Basic Science, Faculty of Science, Erzurum Technical University, Erzurum 25700, Turkey.

出版信息

Curr Comput Aided Drug Des. 2022;18(5):381-392. doi: 10.2174/1573409918666220818114505.

DOI:10.2174/1573409918666220818114505
PMID:35984020
Abstract

BACKGROUND

Carbonic anhydrases (CAs, EC 4.2.1.1) are metalloenzymes that contain zinc ions on the active side and convert carbon dioxide to bicarbonate in metabolism. Human CA-I and CA-II, which are the most abundant CA isozymes in erythrocytes, have been therapeutic targets in the treatment of glaucoma, hypertension, ulcer, osteoporosis, and, neurological disorders. Benzohydrazides are biologically active compounds, and their various pharmacological effects have been reported.

AIM

In light of this, the objective of this study was to investigate the in vitro effects of benzohydrazide derivatives on the activities of hCA-I and hCA-II, determine the compounds as selective inhibitors for these isoenzymes, and estimate the inhibition mechanism through molecular docking studies.

METHODS

In this work, we synthesized the 10 different derivatives of benzohydrazide containing various functional group of different positions.

RESULTS

As a result, all benzohydrazide derivatives inhibited both isozymes in vitro and 2-amino 3- nitro benzohydrazide (10) was found to be the most efficient inhibitor of both hCA isozymes with the IC values of 0.030 and 0.047 μM, respectively. In the molecular docking studies, 3-amino 2- methyl benzohydrazide (3) had the lowest estimated free binding energies against hCA isozymes as -6.43 and -6.13 kcal/mol.

CONCLUSION

In this study, hCA-I & II isozymes were isolate from human erythrocytes. CA isozymes are one of these target enzymes. WBC hope that the benzohydrazide derivatives, can guide remedies targeting carbonic anhydrase.

摘要

背景

碳酸酐酶(CA,EC 4.2.1.1)是一种金属酶,在活性部位含有锌离子,在代谢中将二氧化碳转化为碳酸氢盐。人红细胞中含量最丰富的同工酶 CA-I 和 CA-II 一直是治疗青光眼、高血压、溃疡、骨质疏松症和神经紊乱的治疗靶点。苯甲酰肼是具有生物活性的化合物,其各种药理作用已被报道。

目的

有鉴于此,本研究的目的是研究苯甲酰肼衍生物对 hCA-I 和 hCA-II 活性的体外影响,确定这些化合物对这些同工酶的选择性抑制剂,并通过分子对接研究估计抑制机制。

方法

在这项工作中,我们合成了 10 种不同位置的不同功能基团的苯甲酰肼衍生物。

结果

所有苯甲酰肼衍生物均在体外抑制两种同工酶,而 2-氨基 3-硝基苯甲酰肼(10)对两种 hCA 同工酶的抑制作用最强,IC 值分别为 0.030 和 0.047 μM。在分子对接研究中,3-氨基 2-甲基苯甲酰肼(3)对 hCA 同工酶的估计自由结合能最低,分别为-6.43 和-6.13 kcal/mol。

结论

在这项研究中,从人红细胞中分离出 hCA-I 和 II 同工酶。CA 同工酶是这些靶酶之一。WBC 希望苯甲酰肼衍生物可以指导针对碳酸酐酶的治疗方法。

相似文献

1
Inhibition Profiles and Molecular Docking Analysis of Benzohydrazide Derivatives on Red Blood Cell Carbonic Anhydrases Isozymes.苯甲酰肼衍生物对红细胞碳酸酐酶同工酶的抑制谱和分子对接分析。
Curr Comput Aided Drug Des. 2022;18(5):381-392. doi: 10.2174/1573409918666220818114505.
2
In vitro and in silico interactions of antiulcer, glucocorticoids and urological drugs on human carbonic anhydrase I and II isozymes.抗溃疡药、糖皮质激素和泌尿科药物对人碳酸酐酶 I 和 II 同工酶的体外和计算机模拟相互作用。
Biopharm Drug Dispos. 2022 Apr;43(2):47-56. doi: 10.1002/bdd.2309. Epub 2022 Feb 4.
3
Investigation of and in silico effects of some novel carbazole Schiff bases on human carbonic anhydrase isoforms I and II.研究几种新型咔唑席夫碱对人碳酸酐酶同工酶 I 和 II 的作用及在计算机上的效果。
J Biomol Struct Dyn. 2022 Sep;40(15):6965-6973. doi: 10.1080/07391102.2021.1892527. Epub 2021 Mar 1.
4
Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.多巴胺化合物对碳酸酐酶同工酶 I、II 和 VI 的影响。
J Enzyme Inhib Med Chem. 2012 Jun;27(3):365-9. doi: 10.3109/14756366.2011.591290. Epub 2011 Jun 23.
5
Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.碳酸酐酶抑制剂。新型 N-取代的 N'-(2-芳甲基硫代-4-氯-5-甲基苯磺酰)胍的合成及分子结构及其对人胞质同工酶 I 和 II 以及跨膜肿瘤相关同工酶 IX 和 XII 的抑制作用。
Eur J Med Chem. 2014 Jan;71:135-47. doi: 10.1016/j.ejmech.2013.10.081. Epub 2013 Nov 10.
6
Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.新型2-(2-芳基甲基硫代-4-氯-5-甲基苯磺酰基)-1-(1,3,5-三嗪-2-基氨基)胍衍生物:对人碳酸酐酶胞质同工酶I和II以及跨膜肿瘤相关同工酶IX和XII的抑制作用、抗癌活性及分子模拟研究
Eur J Med Chem. 2018 Jan 1;143:1931-1941. doi: 10.1016/j.ejmech.2017.11.005. Epub 2017 Nov 4.
7
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.碳酸酐酶抑制剂:N-羟基磺胺类化合物对胞质/肿瘤相关碳酸酐酶同工酶I、II、IX和XII的合成及抑制作用——抑制剂设计中的一种新的锌结合功能
Bioorg Med Chem Lett. 2005 May 2;15(9):2353-8. doi: 10.1016/j.bmcl.2005.02.091.
8
The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.三甲氧基茚满衍生物对人碳酸酐酶同工酶I和II(hCA I和II)的抑制作用。
J Enzyme Inhib Med Chem. 2016;31(1):152-7. doi: 10.3109/14756366.2015.1014476. Epub 2015 Feb 20.
9
The effects of some bromophenols on human carbonic anhydrase isoenzymes.某些溴酚对人碳酸酐酶同工酶的影响。
J Enzyme Inhib Med Chem. 2016 Aug;31(4):603-7. doi: 10.3109/14756366.2015.1054820. Epub 2015 Jul 2.
10
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.碳酸酐酶抑制剂:新型磺酰胺类化合物,包含1,3,5-三嗪部分,作为胞质和肿瘤相关碳酸酐酶同工酶I、II和IX的抑制剂。
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3102-8. doi: 10.1016/j.bmcl.2005.04.056.